{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:09:38Z","timestamp":1790662178229,"version":"4.1.0"},"reference-count":45,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Cardiol"],"abstract":"<jats:p>Coronary functional abnormalities are frequent causes of angina pectoris, particularly in patients with unobstructed coronary arteries. There is a spectrum of endotypes of functional coronary abnormalities with different mechanisms of pathology including enhanced vasoconstriction (i.e. coronary artery spasm) or impaired vasodilatation, such as impaired coronary flow reserve or increased microvascular resistance. These vasomotor abnormalities can affect various compartments of the coronary circulation such as the epicardial conduit arteries and\/or the coronary microcirculation. Unequivocal categorisation and nomenclature of the broad spectrum of disease endotypes is crucial both in clinical practice as well as in clinical trials. This article describes the definitions of coronary functional abnormalities with currently accepted cut-off values, as well as diagnostic methods to identify and distinguish endotypes. The authors also provide a summary of contemporary data on the prevalence of the different endotypes of coronary functional abnormalities and their coexistence.<\/jats:p>","DOI":"10.15420\/ecr.2021.14","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T18:27:48Z","timestamp":1638901668000},"source":"Crossref","is-referenced-by-count":9,"title":["Definitions and Epidemiology of Coronary Functional Abnormalities"],"prefix":"10.15420","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-3115","authenticated-orcid":false,"given":"Andreas","family":"Seitz","sequence":"first","affiliation":[{"name":"Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7668-9834","authenticated-orcid":false,"given":"Johanna","family":"McChord","sequence":"additional","affiliation":[{"name":"Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-6859","authenticated-orcid":false,"given":"Raffi","family":"Bekeredjian","sequence":"additional","affiliation":[{"name":"Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4549-9901","authenticated-orcid":false,"given":"Udo","family":"Sechtem","sequence":"additional","affiliation":[{"name":"Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2253-2828","authenticated-orcid":false,"given":"Peter","family":"Ong","sequence":"additional","affiliation":[{"name":"Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Kaski JC, Crea F, Gersh BJ, Camici PG. Reappraisal of ischemic heart disease. Circulation 2018;138:1463\u201380. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.031373; PMID:\u00a030354347.","DOI":"10.1161\/circulationaha.118.031373"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Ong P, Camici PG, Beltrame JF, et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol 2018;250:16\u201320. https:\/\/doi.org\/10.1016\/j.ijcard.2017.08.068; PMID:\u00a029031990.","DOI":"10.1016\/j.ijcard.2017.08.068"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Beltrame JF, Crea F, Kaski JC, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 2017;38:2565\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehv351; PMID:\u00a026245334.","DOI":"10.1093\/eurheartj\/ehv351"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Ford TJ, Ong P, Sechtem U, et al. Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how, and when. JACC Cardiovasc Interv 2020;13:1847\u201364. https:\/\/doi.org\/10.1016\/j.jcin.2020.05.052; PMID:\u00a032819476.","DOI":"10.1016\/j.jcin.2020.05.052"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Jespersen L, Abildstrom SZ, Hvelplund A, Prescott E. Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris. Clin Res Cardiol 2013;102:571\u201381. https:\/\/doi.org\/10.1007\/s00392-013-0568-z; PMID:\u00a023636227.","DOI":"10.1007\/s00392-013-0568-z"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ford TJ, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial. J Am Coll Cardiol 2018;72:2841\u201355. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.006; PMID:\u00a030266608.","DOI":"10.1016\/j.jacc.2018.09.006"},{"key":"ref6","unstructured":"Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425; PMID:\u00a031504439."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Nishimiya K, Suda A, Fukui K, et al. Prognostic links between OCT-delineated coronary morphologies and coronary functional abnormalities in patients with INOCA. JACC Cardiovasc Interv 2021;14:606\u201318. https:\/\/doi.org\/10.1016\/j.jcin.2020.12.025; PMID:\u00a033736768.","DOI":"10.1016\/j.jcin.2020.12.025"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Martinez Pereyra V, Hubert A, Seitz A, et al. Epicardial and microvascular coronary spasm in the same patient? Acetylcholine testing pointing towards a common pathophysiological background. Coron Artery Dis 2020;31:398\u20139. https:\/\/doi.org\/10.1097\/MCA.0000000000000829; PMID:\u00a031658150.","DOI":"10.1097\/mca.0000000000000829"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Konst RE, Damman P, Pellegrini D, et al. Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm. Int J Cardiol 2021;333:14\u201320. https:\/\/doi.org\/10.1016\/j.ijcard.2021.02.079; PMID:\u00a033711394.","DOI":"10.1016\/j.ijcard.2021.02.079"},{"key":"ref10","unstructured":"Seitz A, Feenstra R, Konst RE, et al. Abstract: Intracoronary nitroglycerine is more effective in preventing epicardial spasm than microvascular spasm during acetylcholine provocation testing. Clinical Research in Cardiology 2021;110:1350."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ong P, Safdar B, Seitz A, et al. Diagnosis of coronary microvascular dysfunction in the clinic. Cardiovasc Res 2020;116:841\u201355. https:\/\/doi.org\/10.1093\/cvr\/cvz339; PMID:\u00a031904824.","DOI":"10.1093\/cvr\/cvz339"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Seitz A, Beck S, Pereyra VM, et al. Testing acetylcholine followed by adenosine for invasive diagnosis of coronary vasomotor disorders. J Vis Exp 2021;168. https:\/\/doi.org\/10.3791\/62134; PMID:\u00a033616102.","DOI":"10.3791\/62134"},{"key":"ref13","unstructured":"Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women\u2019s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010;55:2825\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2010.01.054; PMID:\u00a020579539."},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"AlBadri A, Bairey Merz CN, Johnson BD, et al. Impact of abnormal coronary reactivity on long-term clinical outcomes in women. J Am Coll Cardiol 2019;73:684\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.040; PMID:\u00a030765035.","DOI":"10.1016\/j.jacc.2018.11.040"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Suppogu N, Wei J, Quesada O, et al. Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease. Int J Cardiol 2021;333:35\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2021.02.064; PMID:\u00a033662486.","DOI":"10.1016\/j.ijcard.2021.02.064"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Broyd CJ, Hernandez-Perez F, Segovia J, et al. Identification of capillary rarefaction using intracoronary wave intensity analysis with resultant prognostic implications for cardiac allograft patients. Eur Heart J 2018;39:1807\u201314. https:\/\/doi.org\/10.1093\/eurheartj\/ehx732; PMID:\u00a029253131.","DOI":"10.1093\/eurheartj\/ehx816"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Tsagalou EP, Anastasiou-Nana M, Agapitos E, et al. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2008;52:1391\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2008.05.064; PMID:\u00a018940529.","DOI":"10.1016\/j.jacc.2008.05.064"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Sorop O, van den Heuvel M, van Ditzhuijzen NS, et al. Coronary microvascular dysfunction after long-term diabetes and hypercholesterolemia. Am J Physiol Heart Circ Physiol 2016;311:h1339\u201351. https:\/\/doi.org\/10.1152\/ajpheart.00458.2015; PMID:\u00a027591223.","DOI":"10.1152\/ajpheart.00458.2015"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Sechtem U, Brown D, Godo S, et al. Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease). Cardiovasc Res 2020;116:771\u201386. https:\/\/doi.org\/10.1093\/cvr\/cvaa005; PMID:\u00a031958128.","DOI":"10.1093\/cvr\/cvaa005"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Suda A, Takahashi J, Hao K, et al. Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease. J Am Coll Cardiol 2019;74:2350\u201360. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1056; PMID:\u00a031699275.","DOI":"10.1016\/j.jacc.2019.08.1056"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Ford TJ, Yii E, Sidik N, et al. Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders. Circ Cardiovasc Interv 2019;12:e008126. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.119.008126; PMID:\u00a031833416.","DOI":"10.1161\/circinterventions.119.008126"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Spaccarotella CAM, Polimeni A, Migliarino S, et al. Multichannel electrocardiograms obtained by a smartwatch for the diagnosis of ST-segment changes. JAMA Cardiol 2020;5:1176\u201380. https:\/\/doi.org\/10.1001\/jamacardio.2020.3994; PMID:\u00a032865545.","DOI":"10.1001\/jamacardio.2020.3994"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Drexler M, Elsner C, Gabelmann V, et al. Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away. Eur Heart J 2020;41:2224. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa290; PMID:\u00a032346733.","DOI":"10.1093\/eurheartj\/ehaa290"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Adamson PD, Williams MC, Dweck MR, et al. Guiding therapy by coronary CT angiography improves outcomes in patients with stable chest pain. J Am Coll Cardiol 2019;74:2058\u201370. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.085; PMID:\u00a031623764.","DOI":"10.1016\/j.jacc.2019.07.085"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Sugisawa J, Matsumoto Y, Takeuchi M, et al. Beneficial effects of exercise training on physical performance in patients with vasospastic angina. Int J Cardiol 2020;328:14\u201321. https:\/\/doi.org\/10.1016\/j.ijcard.2020.12.003; PMID:\u00a033309635.","DOI":"10.1016\/j.ijcard.2020.12.003"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Bechsgaard DF, Hove JD, Michelsen MM, et al. Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: an iPOWER substudy. Clin Physiol Funct Imaging 2021;41:85\u201394. https:\/\/doi.org\/10.1111\/cpf.12669; PMID:\u00a033030280.","DOI":"10.1111\/cpf.12669"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med 2010;362:886\u201395. https:\/\/doi.org\/10.1056\/NEJMoa0907272; PMID:\u00a020220183.","DOI":"10.1056\/nejmoa0907272"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Shaw LJ, Merz CN, Pepine CJ, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health\u2013National Heart, Lung, and Blood Institute-sponsored Women\u2019s Ischemia Syndrome Evaluation. Circulation 2006;114:894\u2013904. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.609990; PMID:\u00a016923752.","DOI":"10.1161\/circulationaha.105.609990"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Reis SE, Holubkov R, Conrad Smith AJ, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 2001;141:735\u201341. https:\/\/doi.org\/10.1067\/mhj.2001.114198; PMID:\u00a011320360.","DOI":"10.1067\/mhj.2001.114198"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Ong P, Athanasiadis A, Borgulya G, et al. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol 2012;59:655\u201362. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.015; PMID:\u00a022322081.","DOI":"10.1016\/j.jacc.2011.11.015"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Aribas E, van Lennep JER, Elias-Smale SE, et al. Prevalence of microvascular angina among patients with stable symptoms in the absence of obstructive coronary artery disease: a systematic review. Cardiovasc Res 2021. https:\/\/doi.org\/10.1093\/cvr\/cvab061; PMID:\u00a033677526; epub ahead of press.","DOI":"10.1093\/cvr\/cvab061"},{"key":"ref32","unstructured":"Seitz A, Pirozzolo G, Mart\u00ednez Pereyra V, et al. Abstract 13340: Microvascular angina is more frequently associated with microvascular spasm than with impaired microvascular vasodilator capacity. Circulation 2019;140(Suppl 1):A13340."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Ong P, Athanasiadis A, Hill S, et al. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) study. J Am Coll Cardiol 2008;52:523\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2008.04.050; PMID:\u00a018687244.","DOI":"10.1016\/j.jacc.2008.04.050"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Niccoli G, Camici PG. Myocardial infarction with non-obstructive coronary arteries: what is the prognosis? Eur Heart J Suppl 2020;22(Suppl E):e40\u20135. https:\/\/doi.org\/10.1093\/eurheartj\/suaa057; PMID:\u00a032523437.","DOI":"10.1093\/eurheartj\/suaa057"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Pirozzolo G, Seitz A, Athanasiadis A, et al. Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA). Clin Res Cardiol 2020;109:246\u201354. https:\/\/doi.org\/10.1007\/s00392-019-01507-w; PMID:\u00a031236694.","DOI":"10.1007\/s00392-019-01507-w"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Montone RA, Niccoli G, Fracassi F, et al. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J 2018;39:91\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehx667; PMID:\u00a029228159.","DOI":"10.1093\/eurheartj\/ehx667"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Probst S, Seitz A, Martinez Pereyra V, et al. Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries. Eur Heart J Acute Cardiovasc Care 2021;10:380\u20137. https:\/\/doi.org\/10.1177\/2048872620932422; PMID:\u00a032508106.","DOI":"10.1177\/2048872620932422"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Crea F, Bairey Merz CN, Beltrame JF, et al. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization. Eur Heart J 2019;40:2455\u201362. https:\/\/doi.org\/10.1093\/eurheartj\/ehy857; PMID:\u00a030608528.","DOI":"10.1093\/eurheartj\/ehy857"},{"key":"ref39","unstructured":"Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet 2018;391:31\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(17)32714-9; PMID:\u00a029103656."},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Pirozzolo G, Seitz A, Martinez Pereyra V, et al. Different vasoreactivity of arterial bypass grafts versus native coronary arteries in response to acetylcholine. Clin Res Cardiol 2021;110:172\u201382. https:\/\/doi.org\/10.1007\/s00392-020-01694-x; PMID:\u00a032613293.","DOI":"10.1007\/s00392-020-01694-x"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Ong P, Athanasiadis A, Perne A, et al. Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis. Clin Res Cardiol 2014;103:11\u20139. https:\/\/doi.org\/10.1007\/s00392-013-0615-9; PMID:\u00a023995322.","DOI":"10.1007\/s00392-013-0615-9"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Aziz A, Hansen HS, Sechtem U, et al. Sex-related differences in vasomotor function in patients with angina and unobstructed coronary arteries. J Am Coll Cardiol 2017;70:2349\u201358. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.016; PMID:\u00a029096805.","DOI":"10.1016\/j.jacc.2017.09.016"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Vermeltfoort IA, Raijmakers PG, Riphagen II, et al. Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clin Res Cardiol 2010;99:475\u201381. https:\/\/doi.org\/10.1007\/s00392-010-0159-1; PMID:\u00a020407906.","DOI":"10.1007\/s00392-010-0159-1"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Murthy VL, Naya M, Taqueti VR, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 2014;129:2518\u201327. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.008507; PMID:\u00a024787469.","DOI":"10.1161\/circulationaha.113.008507"}],"container-title":["European Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2021.14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T15:18:43Z","timestamp":1640704723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2021.14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":45,"URL":"https:\/\/doi.org\/10.15420\/ecr.2021.14","relation":{},"ISSN":["1758-3764","1758-3756"],"issn-type":[{"value":"1758-3764","type":"electronic"},{"value":"1758-3756","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"article-number":"e51"}}